Relmada Therapeutics, Inc. (RLMD) short interest & options flow
NASDAQRelmada Therapeutics heads into tonight's earnings print carrying a short position that has nearly doubled in six weeks — yet the borrow market tells a strikingly different story about conviction. Short interest has climbed to 19% of the free float, up from roughly 10% at the end of June — an 83% jump in shares short over one month. That is a large and rapid accumulation. Yet the…
RLMD cost to borrow spikes 279% in one week to 0.42%, though borrowing remains cheap despite short interest rising 9% to 8.2% of float.
- Market cap
- $455M
- Next earnings
- 12 Nov 2026
Key data as of 11 Nov 2026
Latest signals on RLMD
- Cost to Borrow
RLMD cost to borrow spikes 279% in one week to 0.42%, though borrowing remains cheap despite short interest rising 9% to 8.2% of float.
RLMD news and analysis
RSSNo long-form analysis yet for RLMD. Pulse alerts and the live data picture are available on ORTEX.
Open RLMD on ORTEX →Want the live picture for RLMD?
Short interest updated daily, real-time options flow, analyst consensus deltas, 13F positioning, ORTEX Alpha signals, and every article ORTEX publishes for RLMD — free to start on ORTEX.
Sign up for free →Open RLMD on ORTEX